ServicesSoftwareCase StudiesScience & Technology
Who We Are

A Science and Technology Company

The clinical development of drugs and devices is crucial for human welfare.
Our mission is to improve success rates in this endeavor.

We do this by improving the design and implementation of clinical trials through the innovative application of statistical science, operations research, and information technology.

We are leaders in the design and implementation of adaptive clinical trials.

What We Do

We provide unrivalled biostatistics and operations research knowledge to our customers.
Our knowledge is available in the form of both software and services. This knowledge, supported by our trial implementation capabilities, is what makes us different.

Software
Our statistical software for designing every type of trial, including adaptive designs, is the industry standard. We also provide software for supporting Data Monitoring Committees, monitoring patient recruitment, and for implementing adaptive clinical trials.

Services
We provide strategic consulting on the statistical design of individual trials as well as development programs. We offer innovative approaches to clinical development. In particular, we are leaders in the design and conduct of adaptive trials. All our customers believe and understand this once they've worked with us.

Cytel Clinical Research Services covers the scientifically essential aspects of trial implementation – the acquisition, quality assurance, analysis, and interpretation of data, and their presentation to Data Monitoring Committees, sponsors, and regulatory authorities.

Our Values and Beliefs

We believe that if you don’t get the trial design right, nothing else matters; and that every sponsor should evaluate the option of an adaptive design.

We value excellence in implementation, with an emphasis on obtaining the maximum useful information for the money spent and enabling the best decisions to be made about the candidate drug or device.

We are committed to a collaborative style of working. Clients come to us because they want us to give them our best advice, and not just follow orders. We are not just another CRO.

We are committed to helping our customers uphold the highest standards of scientific rigor, statistical validity, and data quality in all our engagements.

Who We Work With

All the major pharmaceutical, biotech and medical device companies are our customers.
We also work well with dozens of smaller biotech and specialty pharma companies throughout the world. We work best with those who want to innovate in clinical development in order to improve success rates.

We also count among our customers and research partners many academic and medical centers, as well as government and regulatory agencies worldwide.

Our research collaborations have led to the development of innovative scientific methods and cutting edge technology.

 

A multi-center randomized clinical trial is among the most difficult scientific experiments to carry out. To be successful, it requires very careful attention to the trial design, interim monitoring, data quality control, and analysis.
Marvin Zelen
Harvard School of Public Health

 
 

Properly conducted randomised clinical trials, with appropriate statistical and scientific rigor, are the only reliable basis for evaluating the efficacy and safety of new treatments.
Stuart Pocock,
London School of Hygiene and Tropical Medicine

 
 

Working together with Cytel allowed our team to move from research to reality with swiftness not possible without Cytel. We now have validated tools to help guide our innovative trial design decision-making much more knowledgeably.
Joseph Heyse
Merck Research Labs

 
 

Cytel's work on the trial design, simulation and FDA discussions was instrumental in obtaining regulatory acceptance for the proposed methodology in implementing a groundbreaking adaptive trial.
Simona Skerjanec
The Medicines Company

 
  and